A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a placebo‐controlled, double‐blind trial to evaluate the safety, tolerability,pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of TQF6422Injection in overweight or obese healthy participants.
Epistemonikos ID: e5b40d9007d17f7ed98789fcfea7fc4fb9523764
First added on: Sep 01, 2026